Trial Profile
Two-Arm Parallel Phase 2 Clinical Trial of Atezolizumab With or Without Low Dose Local Radiotherapy (2 x 2Gy) in Patients With Relapsed/Refractory Advanced Stage Follicular Lymphoma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Atezolizumab (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 19 Dec 2019 Status changed from recruiting to discontinued.
- 16 Mar 2018 New trial record